Alzheimer’s disease tagged posts

Neuroglobin expression in the human brain, from the Allen Human Brain Atlas. Credit: brain-map.org

A team at the MRC Clinical Sciences Centre (CSC), Imperial College London, has found an important part of the machinery that switches on a gene known to protect against Alzheimer’s Disease. Working in collaboration with scientists at the Hong Kong University (HKU) and the Erasmus University in Rotterdam, CSC associate professor Richard Festenstein explored the steps by which this Neuroglobin gene is gradually switched on, or up-regulated. Neuroglobin has previously been shown to protect against Alzheimer’s disease in mice in which it makes the protective Neuroglobin...

Schematic of mice with dysfunctional and functional Wnt signaling Source: Alzheimer’s Research UK

Memory loss in mice has been reversed following the discovery of new information about a key mechanism underlying the loss of nerve connectivity in the brain. The team found Wnt proteins play a key role in the maintenance of nerve connectivity in the adult brain and could become targets for new treatments that prevent and restore brain function in neurodegenerative diseases.

Professor Salinas said: “Synapses are absolutely critical to everything that our brains do. When these important communication points are lost, nerve cells cannot exchange information and this leads to symptoms like memory and thinking problems...

Amyloid plaque reduction with aducanumab: example amyloid PET images at baseline and week 54. Axial slice shows anatomical regions in posterior brain putatively related to Alzheimer’s disease pathology

The researchers furthermore demonstrated in an early stage clinical study that, after 1 year of treatment with Aducanumab, cognitive decline could be significantly slowed in antibody-treated patients as opposed to the placebo group. Although the causes of Alzheimer’s disease are still unknown, it is clear that the disease commences with progressive amyloid deposition in the brains of affected persons between 10 to 15 years before the emergence of initial clinical symptoms such as memory loss...

Auriel Willette used data from brain scans and memory tests to track the progression of Alzheimer’s disease. Photo by Blake Lanser

Iowa State University researchers have identified a protein essential for building memories that appears to predict the progression of memory loss and brain atrophy in Alzheimer’s patients. The findings also suggest there is a link between brain activity and the presence of the protein neuronal pentraxin-2, or NPTX2. The research, published in the journal Brain, Behavior and Immunity, found a correlation between higher levels of NPTX2 and better memory and more brain volume. Lower levels of the protein were associated with diminished memory and less volume.

“NPTX2 seems to exert a protective effect,” Swanson said...